Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks like a little profit taking and panic selling this morning. Overall a great week thus far; however, instill expect the slow climb back to .04 after lunch when nerves settle down and Common sense prevails. Fundamentally nothing has changed, so no reason to freak out.
Good Luck Team!
IMHO
The timeframe when the deal took place was about the same time Peddar came on board. The general belief is that Delcath BOD and Simpson received some type of offer pending cleaning up the books and regaining control of their 20+ Patents. Once the SP dropped below the requirement last year to stay listed on NASDAQ, the BOD recommended a R/S. Well, the shareholders said no, and then the company had to be delisted for compliance and found itself on the OTC. With all that was happening, they needed money in order to keep the trials going, so they found no choice but to hop into bed with HB...whom wanted the Company to fail because HB wanted all of Delcath's patents. It appears now that DCTH was able to find a way to give back the money after doing the horrible R/S last year, and then issuing another 123M shares and cash to HB. HB made out well by getting to sell their shares at a huge conversion price! Every sell they made down to about 2.5 cents was still profit! They had no incentive to let the SP organically rise...they were making money hand over foot no matter the share price!
Then the selling stops...which is where we are now. DCTH has control of their patents, DCTH has no outstanding debt, DCTH has agreed Protocol Assessment with the FDA for relaxed enrollment criteria for their FOCUS Trial, DCTH is working with FDA for early approval, DCTH has received their blessing from the Independent Safety Monitoring Committee on the FOCUS Trial, DCTH intends to start the Phase 3 ICC Trial in March, DCTH has completed more than 500 procedures in Europe, DCTH is approved by the EU for treatments in Europe!
NEXT UP FDA APPROVAL!
IMHO
HB received both shares and cash! 95% or more of their shares were dumped by MAXM /CDEL over the past month. They (HB) currently own less than 4.9%, and all DCTH loans are paid...patent leans are free and clear!
GlobeNewswireDecember 29, 2017
NEW YORK, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces on December 28, 2017, it entered into exchange agreements (collectively, “Exchange Agreements”), each by and between the Company and an investor from its June 2016 private placement of senior secured convertible notes (as further exchanged, the “Notes”) originally issued pursuant to that certain Securities Purchase Agreement, dated June 6, 2016, by and among the Company and such investors. Pursuant to the Exchange Agreements, we (i) extinguished our remaining $3,027,408 in outstanding obligations under the Notes in full, (ii) obtained a release of restrictions on $2,046,897.66 in restricted cash held in our control accounts, (iii) issued to the investors shares (the “Shares”) of our common stock (or rights (“Rights”) to receive common stock to the extent such issuance of Shares would otherwise result in the beneficial ownership by any such investor of more than 4.9% or 9.9% of our issued and outstanding stock), as applicable, of an aggregate of 123,708,735 shares of our common stock (in each case, subject to trading restrictions set forth in leak out agreements the Company separately entered into with each investor (collectively, the “Leak-Out Agreements”)) and (iv) a cash payment to the investors of $829,830.54 from the restricted cash held in our control accounts. The number of shares of the Company’s issued and outstanding common stock immediately following issuance of the initial Shares to the investors is 114,054,852.
GlobeNewswireFebruary 1, 2018
NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that it has satisfied all of its obligations under the privately placed senior secured convertible notes issued to two institutional investors in June 2016. On December 28, 2017, Delcath entered into exchange agreements with two institutional investors pursuant to which those investors were issued, in exchange for satisfaction in full of those notes, shares of its common stock (or rights to receive common stock to the extent such issuance of Shares would otherwise result in the beneficial ownership by any such investor of more than 4.9% or 9.9% of our issued and outstanding stock), as applicable, in an aggregate of 123,708,735 shares of our common stock. As of January 25, 2018, all of the Rights were exercised, and neither investor owns more than 4.9% of the issued and outstanding shares of Delcath’s common stock.
Chart is looking better each day!
Hope to cross that 50 Day Moving Average tomorrow!
Accumulation is picking up
RSI is moving back towards 30
MACD is about to flip
Could it be that the times are changing....
IMHO
http://stockcharts.com/h-sc/ui?s=DCTH&p=D&yr=0&mn=2&dy=0&id=p01383968953
Neo, another .005 move today!
Something may go bump in the night...
May we wake up to a nice juicy PR!
I HO
It's looking pretty good here today...buys are out performing the sells!
I'm sure there will be a few of those who are happy with their 30-50% profit and will happily move on. But.....they will also be the ones who will kick themselves in the butt for not holding a few more days and making a 150% profit. Right now we are riding up from the waaaaaaaaay oversold state of afffairs. Getting good around here, and I am glad to be a part of it!
You have to know there are still plenty of people who believe in the science and will want to take a position with the first glimpse of approval.
I believe the whole "COMPASIONATE USE" stance will be the push the FDA needs to get this Phase 3 completed and a priority review will follow to start treatments as soon as possible. Once politics get involved, who knows how quickly this will move through the process towards approval? For first in kind treatments/procedures, the FDA has been known to allow early completion in the past...not often, but has happened. Sure would be a game changer!
IMHO
Well then,
I for one am glad you are not Simpson as others have speculated!
Right now, we don't even know how many are on the offer and if this is one investor or many investors? Heck...we don't even know the SP for an offering?
The company's valuation should be in the hundreds of millions of dollars! Where our market cap is truely a joke and is only due to loss of investor confidence. But get ready, because new investors are coming on board...and the SP will continue to rise as the float gets locked up and buying shares becomes harder and harder. If these new institutional investors hold for the long haul, people will have to pay quite a premium for what is left in the float!
For me personally, I have 3/4 Million shares locked at $3.00 hoping for the buy out!...time will tell, but...When the FDA finally does give the Green Light, everyone and their Mother is going to want to own a piece of a Cancer treatment company!
IMHO
Absolutely Picker!
There is the Mr Hyde to Sam's Dr. Jekyll!
Lots of people looking at this company because they do own the whole organ treatment patents...they own the equipment, the know how, and have proven it commercially Over 500 times!
FDA will almost be forced to get on board at some point!
IMHO
Sounds good Cricket Fan!
And when it shoots past "The Moon", and heads towards "SATURN", you can cover before it gets to "Uranus"
Best of luck shorting Buddy...but your going to end up covering!
IMHO
5 Billion...C'mon man!
Even you know a company with 223 million won't make a jump to 5B...not a chance.
As share prices increase, the amount of shares needed to raise money will be greatly reduced!
Especially if they partner with a huge upfront payment of a couple million/couple hundred million dollars.
Best of luck Sam, but sounds like you just want cheap shares, and are regretting not loading up when the PPS was 30% lower.
IMHO
Welcome Back Rap!
Thank you again Cricket Fan, for your one lined warnings!!!
Don't know how else I would conduct my trades without those saviors out there like you! Those who create accounts just to warn investors of one particular stock are hard to find!
DCTH may be many things, but to us DREAMERS, it is the stock we prefer to be invested in at the time being. You can either be with us or against us...your choice, but your warnings without merit or factual data fall upon deaf ears.
IMHO
That's right Wanderer, Slow and Steady still wins the race!
I hope it is a marathon worth of green!
Good luck buddy!
IMHO
NEO,
another spectacular.002 move today!
If we string enough of these together, we will be in that happy place that you want to be in!
Looks like the major selling is over, and the accumulation is creeping up!
Stocking up on shares at this ridiculously low level!
IMHO
Another private placement of 2,325,540 shares at .50 with warrants at .75 to raise $1.16M
Sure will be nice to get results out and flush all the warrants so they won't have to keep doing these small raises!
Great Guy,
You are like the Yoda of the trading realm! It appears that the force is strong with you! Hopefully you can do your Jedi mind tricks and impart your trading prowess upon each and every one of us! Here I am getting excited about picking up another .002 today and you are feeling nickels and dimes in the force! Taking DCTH to a new place you are...
IMPRESSED WITH YOU I AM!!!
IMHO
Hush, great entry point!
I am sure you will do well here!
IMHO
Thanks for your valued input Cricfan!
I will always dream! Hopefully dreaming while laying on my pillow of cash made from believing in DELCATH!
Good luck in your positions!
IMHO
Yes, low volume? Everyone is holding strong! More buying today than selling! Looks like MAXM is nonexistent, and now CDEL appears to be complete too...
I for one can't wait till the next PR from the company. I personally look for a company under negotiations/entering into agreement type PR, but also wouldn't be surprised to just see a published way forward PR as well.
Time will tell.
IMHO
You must be in one of those places where recreational marijuana is legal...lol
I want what your having!
Good Luck flipping DCTH!
Selling at .05 could be dangerous...especially when it keeps heading up!
IMHO
Lol...hopefully it will be one in the same!
Can't wait to hear what the future brings for DCTH, but it sure looks positive right now! Their Phase 3 ICC Study is expected to start in March according to Clinicaltrials.gov website! That is after they received new Protocol assessment agreement from FDA to stop their phase 2 and go straight to phase 3 based on the studies and completions FROM Europe.
The fact that both Athenex and Delcath are both in the same area of the country and are both into cancer research may just be coincidental....but it may also be planned?
IMHO
All signs point to up!
Whether your a technicals kind of person, or a chart kind of person, DCTH Fundamentals are good at this time, and there is a lot of room for this to run! Lots of dots are lined up, and huge positives are being announced. Time will ultimately tell...
IMHO
Looks like you are on the wrong board!
Good luck where ever you're waiting... stay warm!
IMHO
Welcome back Wanderer, things are really looking up for DCTH. Looks like they have their proverbial ducks in a row and are ready to make a serious move. Lots of speculation around here that ATNX may be interested in a buyout, merger, or partnership? They just did a $60M cash raise and set aside $20 million for possible acquisitions...
DCTH has been working hard the past couple months getting cleaned up...
Best of Luck here!
IMHO
Any move upwards, is a move upwards...whether that be .001, or .01,.....hopefully .10 in the near future! I will take a 5%-7% daily gain for the next few weeks to call it a positive trend.
Yes, investor confidence was greatly diminished over the previous months while the PPS did a free-fall...and I am sorry to all Longs who suffered through that!
Believe me I do! I have been on the wrong end of that falling Knife before as well. But I also truly believe the floor is in, and looks like the only direction we have to move right now is up! With the positives we have in the back pocket, and the WAAAAAAAAY OVERSOLD position we find ourselves in, Accumulation at higher lows is the only right direction to move. Sure, there will be small sellers who have bought in at the lowest .025 level making their 50% flip, but those will subside as well.
Call me Optimistic, but I see the glass as Half-Full and the next Pitcher is coming!
IMHO
DCTH...starting to move up!
With all the pressure on the other markets, it should help the Biotechs start to gain traction. Fortunately for Delcath, they are in a pretty good position right now. As mentioned by so many other posters on this board, lots of positives!
Completed the exit from the Hudson Bay convertible note,
Paid the Leins on all their patents...free and clear!
Completed 500th Commercial procedure in Europe,
Already approved and commercialized by the EU,
Positive reviews in peer publications,
Special protocol assessment with FDA on FOCUS trial to relax enrollment criteria,
Special Protocol Assessment with FDA to begin Phase 3 ICC Trials,
Independent Data Safety Monitoring Board evaluated safety of FOCUS Trial, and recommended completion of trial without modifications!
FOCUS Trial due to be completed in less than a year!
Delcath is on the move, and I for one am not surprised to see more accumulation, especially when investors start to realize how much more the rewards here are far greater than the risks.
IMHO
DCTH...starting to move up!
With all the pressure on the other markets, it should help the Biotechs start to gain traction. Fortunately for Delcath, they are in a pretty good position right now. As mentioned by so many other posters on this board, lots of positives!
Completed the exit from the Hudson Bay convertible note,
Paid the Leins on all their patents...free and clear!
Completed 500th Commercial procedure in Europe,
Already approved and commercialized by the EU,
Positive reviews in peer publications,
Special protocol assessment with FDA on FOCUS trial to relax enrollment criteria,
Special Protocol Assessment with FDA to begin Phase 3 ICC Trials,
Independent Data Safety Monitoring Board evaluated safety of FOCUS Trial, and recommended completion of trial without modifications!
FOCUS Trial due to be completed in less than a year!
Delcath is on the move, and I for one am not surprised to see more accumulation, especially when investors start to realize how much more the rewards here are far greater than the risks.
IMHO
Maybe it will be amended 5 or 6 more times before it is actually official?
Maybe frogs will grow wings too?
The positives of the company strongly point towards an upward swing in PPS too!
Time will tell.
IMHO
You'll be very lonely there waiting!
Hold your breath and wait for the rest of us to arrive!
I'd be willing to bet 1.00 will be here before .001!
Good Luck poster...looks like we know your position here!
IMHO
Looks like nothing new...only another re-release with another /a...amendment.
Won't be news until warrants and shares are actually priced and dates are entered.
Company is just updating to keep it active if/when they may use it.
The fact they keep it active and not actually release it makes me think a deal of some type is imminent.
Time will tell?
IMHO
Pete, I have you on ignore, because of all your negative posts...as I recommend others to do the same.
However, I will entertain your assumptions.
Did you get a memo that said Issued and outstanding shares were increased to 1B?
Because I read all the public filings and I only see a number closer to 250M
I am not sure your purpose here on this board, but posting one line negative posts provides no useful data on DCTH Stock?
I understand being upset if you bought in prior to the last R/S, but things are looking much better now.
Zero debt,
Patents free and clear,
Reduced enrollment specifications from the FDA,
SPA for phase 3 ICC Trial,
Phase 3 FOCUS Trial due to be complete in less than a year,
More than 500 treatments in Europe,
Approved by the EU,
DCTH is on a path to Buyout, Partnership, or Merger....they could even go at it alone at this point should they chose to do so.
Even if they do increase shares for financing, look at companies like SIRI, NOK, CSCO, etc... all with Billions of shares issued and outstanding...all are worth several dollars per share!
Good Luck Bashing, if that is how you trade; however, I recommend buying at these levels!
You'll have a better chance to make money!
Good Luck My Friend!
IMHO
Ummmm Yes? Hence the comment about being Feb and halfway over? January was first 1/3, Feburary will be 2nd 1/3, and march will be last 1/3. Or February 14th will be first 1/2 and March 31 will be 2nd 1/2.
Ok...being sarcastic, I know!
I'm just really excited as we get closer to the Combo results and quite possibly Mono results too!
Best of luck Michel, your posts are well thought out and contribute well to this board.
IMHO
Ocular Melanoma may be the closest alligator to the boat right now, but once proven, it opens up the door to many other possibilities. Once the first treatment is approved by the FDA, safety and efficacy study times for say...ICC could be greatly reduced. We still don't know what the special protocol assessment with the FDA will be in regards to the ICC trial? But I can only imagine it will be streamlined with the OM FOCUS trial completed.
Going to be real interesting around here in the near future...
IMHO
Great find Ben,
Thanks for the good DD!
I have a strong feeling that DCTH is going to continue to creep up as the huge selling pressure is over.
Just too many positives here to keep it held at these levels...the Accumulation is starting to pick up!
IMHO
ready to start making waves!
Here's to a good week!
Let's go Delcath!
IMHO
I hear you Word.
I'm also invested in a few Phase 3 biotechs. One specifically is loooking for MONO treatment for AIDS instead of the HAART combinations of drugs, and the PPS is floating between 50-55 cents lately. Nothing on the market, no income, and only phase 3 trials going on. Speculation is results by end of quarter one and PPS could jump to 3-5 dollars per share!
I really see no difference in tactics here at DCTH other than loss of investor faith due to the toxic financing that had to take place to regain control of the company's patents. In due time, investor faith will be restored, and I see this walking back towards the .10-.25 range. As long as the company doesn't do anymore toxic financing deals and puts out clear guidance on future direction. This small company could prove to be a goldmine if ran the right way!
Best of luck my friend!
IMHO
Held is held...referenced the wrong share count sure. They only have to register what they hold. They liquidated the other 110M shares immediately as we witnessed with the constant dumping by MAXM. Holding a core position I see as another positive sign that they too see big possibilities here. I believe they will hold to see what happens in the coming weeks. Hopefully something big by end of Q1
IMHO
Guess the best news out of that is that This is now February, and the quarter is about 1/2 over. There are many things that could be announced to make the PPS climb and possibly get the warrants to cash in, but I feel CYDY will do it all at once, or release one small piece of info right after the other in the push to uplist. The Mono data is the true game changer as Pers has emphasized so many times, and with those (positive) results, money will be no object! At that point, someone willing to hold their 50,000 shares could be a millionaire in CYDY. Maybe I'm too bullish here, but very optimistic! I'm holding mine for the long haul! Avg: .56 and may add more if it drops below .50
Best of Luck everyone!
IMHO
Looks like they are claiming to still own 11M shares and warrants at this point. Typically wouldn't bother to file the form 13 unless they intend to keep the shares for a little while. Hudson Bay already made their money back and then some with the constant dumping they had been doing over the previous few weeks. Hudson must know something is brewing here as well if they intend to hold a small portion. With money in the bank, they are holding free shares and are willing to take the gamble along with the rest of us. Good to know a portion of the issued/float is still locked up for now.
Best of Luck JH!
IMH
CARRY ON!!!!
Sam, I can use caps too!
I know what the trial website reads, and I know it was formerly 240 patients too! Why do you want to second guess everything I post? The company has been working with the FDA as we just saw the special
Protocol agreement that reduced the enrollment requirements...now it states 200 patients.
For those who question... check it out yourself.
https://clinicaltrials.gov/ct2/show/NCT02678572?id=NCT02483078+OR+NCT02859961+OR+NCT02737306+OR+NCT02657330+OR+NCT03266042+OR+NCT02415036+OR+NCT02678572+OR+NCT03086993&rank=5&load=cart
Trials are only marked as updated when changes to a study record were made by the study's sponsor or investigator...
When FDA reduced the enrollment criteria, they also reduced the patient criteria as reflected on the actual trial website as monitored by the National Institute of Health.
I understand there are several trials going on at the same time, so I spoke a little out of context...Sam spot on with the FOCUS trial, I pulled up the other phase 3...my bad! I own it!
Sorry...??
IMHO